Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of IDSIQ in Insomnia Patients
NCT03056053Phase 2Completed
- Sponsor
- Idorsia
- Start
- Feb 2017
- Primary completion
- Apr 2017
- Countries
- 2
01
Overview
A Phase 2 trial of zolpidem sublingual tablet in insomnia disorder, sponsored by Idorsia. Started Feb 2017; status: completed.
02
Drugs
zolpidem sublingual tablet
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT03056053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03056053.